Authors' reply to letter: He who controls Clostridia and Bacteroidia controls the gut microbiome: The concept of targeted probiotics to restore the balance of keystone taxa in irritable bowel syndrome
- PMID: 38764218
- DOI: 10.1111/nmo.14820
Authors' reply to letter: He who controls Clostridia and Bacteroidia controls the gut microbiome: The concept of targeted probiotics to restore the balance of keystone taxa in irritable bowel syndrome
References
REFERENCES
-
- Sitkin S, Pokrotnieks J. He who controls Clostridia and Bacteroidia controls the gut microbiome: the concept of targeted probiotics to restore the balance of keystone taxa in irritable bowel syndrome. Neurogastroenterol Motil. 2024. https://onlinelibrary.wiley.com/doi/full/10.1111/nmo.14805
-
- Mullish BH, Michael DR, Dabcheva M, et al. A double‐blind, randomized, placebo‐controlled study assessing the impact of probiotic supplementation on the symptoms of irritable bowel syndrome in females. Neurogastroenterol Motil. 2024;36(4):e14751. doi:10.1111/NMO.14751
-
- ISRCTN–ISRCTN90136957: Can taking probiotics (“friendly” bacteria) reduce upper respiratory tract infections in healthcare workers? Accessed April 18, 2024 https://www.isrctn.com/ISRCTN90136957?q=90136957&filters=&sort=&...
-
- Mullish BH, Michael DR, Webberley TS, et al. The gastrointestinal status of healthy adults: a post hoc assessment of the impact of three distinct probiotics. Benefic Microbes. 2023;14(3):183‐195. doi:10.3920/BM2022.0092
-
- John D, Michael D, Dabcheva M, et al. A double‐blind, randomized, placebo‐controlled study assessing the impact of probiotic supplementation on antibiotic induced changes in the gut microbiome. Front Microb. 2024;3:1359580. doi:10.3389/FRMBI.2024.1359580
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources